Search

everythinglearnresearchcommunity

for

Search:↓

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Lymphoma should be considered in unusual scalp hair loss cases, as treatment can work but may lead to severe complications.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Enhancing Tregs can protect against alopecia areata.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.